Clinical Trial Update: Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating consolidation serplulimab after concurrent chemoradiotherapy in patients with Limited Stage Small Cell Lung Cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Limited Stage Small Cell Lung Cancer | Phase 2 | Status: RECRUITING